A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors.
Principal Investigator: Katriina Peltola
HUS Helsinki University Hospital, Comprehensive Cancer Center
